Table 1.

Comparison of clinical variables of patients with (Patients+) and without (Patients−) a complete diagnostic investigation of lower extremity arteries.

VariableAll PatientsPatients+Patients−p
Patients, no. (%)11260 (53.6)52 (46.4)
Age, mean ± SD, yrs69 ± 8.467.8 ± 8.570.3 ± 8.20.12
Female, no. (%)86 (76.8)47 (78.3)39 (75.0)0.82
Headache, no. (%)59 (52.7)34 (56.7)25 (48.1)0.45
Jaw claudication, no. (%)47 (42.0)23 (38.3)24 (46.2)0.45
Impaired vision, no. (%)41 (36.6)20 (33.3)21 (40.4)0.56
Arm claudication, no. (%)22 (19.6)14 (23.3)8 (15.4)0.35
Leg claudication, no. (%)17 (15.2)17 (28.3)0< 0.01
PMR, no. (%)45 (40.2)24 (40)21 (40.4)1.00
Constitutional symptoms, no. (%)62 (55.4)37 (61.7)25 (49.0)0.25
Time between symptom onset and diagnosis, mean ± SD, wks18.2 ± 21.817.9 ± 19.818.5 ± 24.00.89
C-reactive protein at time of diagnosis, mean ± SD, mg/dl*7.3 ± 5.77.1 ± 5.47.5 ± 6.10.69
ESR at time of diagnosis, mean ± SD, mm/h**75 ± 3480 ± 3570 ± 330.11
Temporal artery halo (CDS), no. (%)58 (51.8)28 (46.7)30 (57.7)0.26
Temporal artery biopsy, no. (%)56 (50.0)28 (46.7)28 (53.8)0.57
Positive temporal artery biopsy, no. (%)42 (75.0)18 (64.3)23 (85.7)0.12
≥ 3 ACR criteria fulfilled, no. (%)7 (68.8)39 (65.0)38 (73.1)0.42
GCA of the carotid arteries (CDS), no. (%)30 (26.8)21 (35.6)9 (17.3)0.05
GCA of the arm arteries (CDS), no. (%)58 (51.8)35 (59.3)23 (44.2)0.18
  • * Reference range < 0.5 mg/dl;

  • ** reference range: men < 20 mm/h; women < 30 mm/h; PMR: polymyalgia rheumatica; ESR: erythrocyte sedimentation rate; CDS: color Doppler sonography; ACR: American College of Rheumatology; GCA: giant cell arteritis.